Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
C275258-1mg | 1mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $46.90 | |
C275258-5mg | 5mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $177.90 | |
C275258-10mg | 10mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $273.90 | |
C275258-25mg | 25mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $615.90 | |
C275258-50mg | 50mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $989.90 | |
C275258-100mg | 100mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $1,499.90 |
Non-CB 1 /CB 2 endocannabinoid receptor ligand
Synonyms | Abnormal cannabidiol|Abn-cbd|22972-55-0|Abnormal-cannabidiol|CAY10429|T4WF2D7YPH|4-[(1R,6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol|CHEMBL499876|Resorcinol, 4-p-mentha-1,8-dien-3-yl-5-pentyl-, (-)-(E)-|1,3-Benzenediol, 4-[(1R |
---|---|
Specifications & Purity | ≥98% |
Storage Temp | Protected from light,Store at -20°C,Desiccated |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | AGONIST |
Mechanism of action | Agonist of GPR18;Agonist of GPR55 |
Product Description |
Abn-CBD is a neurobehaviorally inactive cannabinoid that acts as a selective agonist for GPR55 (EC50 values are 2.5, >30 and >30 μM at GPR55, CB1 and CB2 receptors respectively). Increases phosphorylation of protein kinases in, and migration of, human umbilical vein endothelial cells.
|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | 4-[(1R,6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol |
---|---|
INCHI | InChI=1S/C21H30O2/c1-5-6-7-8-16-12-17(22)13-20(23)21(16)19-11-15(4)9-10-18(19)14(2)3/h11-13,18-19,22-23H,2,5-10H2,1,3-4H3/t18-,19+/m0/s1 |
InChi Key | YWEZXUNAYVCODW-RBUKOAKNSA-N |
Canonical SMILES | CCCCCC1=C(C(=CC(=C1)O)O)C2C=C(CCC2C(=C)C)C |
Isomeric SMILES | CCCCCC1=C(C(=CC(=C1)O)O)[C@@H]2C=C(CC[C@H]2C(=C)C)C |
PubChem CID | 89949 |
Molecular Weight | 314.46 |
CAS Registry No. | 22972-55-0 |
---|---|
PubChem CID | 89949 |
ChEMBL Ligand | CHEMBL499876 |
RCSB PDB Ligand | HVD |
GPCRdb Ligand | abnormal cannabidiol |
Enter Lot Number to search for COA:
Solubility | Soluble in methyl acetate;ethanol (~35 mg/ml);DMSO (~35 mg/ml);DMF (~35 mg/ml);DMSO:PBS (1:3, pH 7.2) (0.25 mg/ml). |
---|---|
Sensitivity | Light sensitive;Moisture sensitive |
1. Járai Z, Wagner JA, Varga K, Lake KD, Compton DR, Martin BR, Zimmer AM, Bonner TI, Buckley NE, Mezey E et al.. (1999) Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.. Proc Natl Acad Sci USA, 96 (24): (14136-41). [PMID:10570211] |